β-catenin expression, DNA ploidy and clinicopathological features in ovarian cancer: A study in 253 patients
- 1 May 2005
- journal article
- Published by Elsevier BV in European Journal Of Cancer
- Vol. 41 (8), 1127-1134
- https://doi.org/10.1016/j.ejca.2005.01.022
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Loss of β-Catenin Is Associated With Poor Survival in Ovarian CarcinomasInternational Journal of Gynecological Pathology, 2004
- Immunohistochemical patterns for α- and β-catenin, E- and N-cadherin expression in ovarian epithelial tumorsGynecologic Oncology, 2004
- Nuclear and cytoplasmic c-myc staining in endometrial carcinoma and their relationship to survivalInternational Journal of Gynecologic Cancer, 2004
- RETRACTED: Cyclooxygenase-2 (COX-2) expression in high-risk premalignant oral lesionsOral Oncology, 2003
- β-catenin nuclear localization is associated with grade in ovarian serous carcinomaGynecologic Oncology, 2003
- Aberrant expression of cell‐cycle regulator cyclin D1 in breast cancer is related to chromosomal genomic instabilityGenes, Chromosomes and Cancer, 2002
- DNA Content as a Prognostic Marker in Patients with Oral LeukoplakiaNew England Journal of Medicine, 2001
- Mutations in the APC tumour suppressor gene cause chromosomal instabilityNature, 2001
- A role for the Adenomatous Polyposis Coli protein in chromosome segregationNature, 2001
- Wnt Signaling in Oncogenesis and Embryogenesis--a Look Outside the NucleusScience, 2000